Human CD27 Ligand (CD27L)

<strong>Human CD27 Ligand (CD27L)</strong>_x000D_ <strong>Catalog number:</strong> B2018486_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~18 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> CD27L_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Hintzen RQ, Lens SM, Beckmann MP, Goodwin RG, Lynch D, van Lier RA. Characterization of the human CD27 ligand, a novel member of the TNF gene family J Immunol. 1994 Feb 15;152(4):1762-73._x000D_ 2: Hintzen RQ, Lens SM, Koopman G, Pals ST, Spits H, van Lier RA. CD70 represents the human ligand for CD27 Int Immunol. 1994 Mar;6(3):477-80._x000D_ 3: Brown GR, Meek K, Nishioka Y, Thiele DL. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes J Immunol. 1995 Apr 15;154(8):3686-95._x000D_ 4: Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas Blood. 1995 Jun 15;85(12):3378-404._x000D_ 5: Seko Y, Takahashi N, Oshima H, Shimozato O, Akiba H, Kobata T, Yagita H, Okumura K, Azuma M, Yazaki Y. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3 J Pathol. 1999 Aug;188(4):423-30._x000D_ 6: Jumper MD, Nishioka Y, Davis LS, Lipsky PE, Meek K. Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands J Immunol. 1995 Sep 1;155(5):2369-78._x000D_ 7: Gruss HJ, Duyster J, Herrmann F. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease Ann Oncol. 1996;7 Suppl 4:19-26._x000D_ 8: Seko Y, Ishiyama S, Nishikawa T, Kasajima T, Hiroe M, Suzuki S, Ishiwata S, Kawai S, Tanaka Y, Azuma M, Kobata T, Yagita H, Okumura K, Nagai R. Expression of tumor necrosis factor ligand superfamily costimulatory molecules CD27L, CD30L, OX40L and 4-1BBL in the heart of patients with acute myocarditis and dilated cardiomyopathy Cardiovasc Pathol. 2002 May-Jun;11(3):166-70._x000D_ 9: Gruss HJ. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily Int J Clin Lab Res. 1996;26(3):143-59._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/9622100">10: Couderc B, Zitvogel L, Douin-Echinard V, Djennane L, Tahara H, Favre G, Lotze MT, Robbins PD. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells Cancer Gene Ther. 1998 May-Jun;5(3):163-75.</a>_x000D_ _x000D_ <strong>Products Related to Human CD27 Ligand (CD27L) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>